Farzana D Pashankar MD, MBBS, MRCP(UK)
Associate Professor of Pediatrics (Hematology / Oncology)
Clinical Interests
Hemoglobinopathies including sickle cell anemia; thalasemia; solid tumors, especially germ cell tumors
Board Certifications
- 2004
- Pediatric Hematology & Oncology, Board Certified
- 2003
- Pediatrics, Board Certified
Patient Care Locations
farzana_pashankarfaculty-clinicsfalsetruefalse
Clinical Trials
| Conditions | Study Title |
|---|---|
| Recurrent or Refractory Solid Tumors | A Phase II Study of Cixutumumab (IMC-A12; IND# 100947) in Combination with Temsirolimus (IND# 61010) in Pediatric Patients with Recurrent or Refractory Solid Tumors (ADVL1221) |


